BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 7957660)

  • 1. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor.
    Kimura K; Matsubara H; Sogoh S; Kita Y; Sakata T; Nishitani Y; Watanabe S; Hamaoka T; Fujiwara H
    J Immunol; 1991 Apr; 146(8):2618-24. PubMed ID: 1901881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans.
    Westergren-Thorsson G; Onnervik PO; Fransson LA; Malmström A
    J Cell Physiol; 1991 Jun; 147(3):523-30. PubMed ID: 2066370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfated glycosaminoglycans of guinea pig basophilic leukocytes.
    Orenstein NS; Galli SJ; Dvorak AM; Silbert JE; Dvorak HF
    J Immunol; 1978 Aug; 121(2):586-92. PubMed ID: 681751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of heparin and other glycosaminoglycans on levels of tissue plasminogen activator and plasminogen activator inhibitor in cultured human umbilical vein endothelial cells.
    Marsh NA; Minter AJ; Chesterman CN
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):133-8. PubMed ID: 1966669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vitro.
    Mueller SN; Thomas KA; Di Salvo J; Levine EM
    J Cell Physiol; 1989 Sep; 140(3):439-48. PubMed ID: 2777882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heparan sulfate-containing fraction of bone marrow stroma induces maturation of HL-60 cells in vitro.
    Luikart SD; Maniglia CA; Furcht LT; McCarthy JB; Oegema TR
    Cancer Res; 1990 Jun; 50(12):3781-5. PubMed ID: 2140291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin and heparan sulfate binding sites on B-16 melanoma cells.
    Biswas C
    J Cell Physiol; 1988 Jul; 136(1):147-53. PubMed ID: 2840440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation-associated changes in the expression of chondroitin sulfate proteoglycan in induced U-937 cells.
    Kolset SO; Ivhed I; Overvatn A; Nilsson K
    Cancer Res; 1988 Nov; 48(21):6103-8. PubMed ID: 2844400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of exogenous glycosaminoglycans on growth and glycosaminoglycan synthesis of cultured human diploid fibroblasts (WI-38).
    Schachtschabel DO; Wever J; Sluke G; Wever G
    Z Gerontol; 1979; 12(1):19-26. PubMed ID: 433377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertoli cells in culture secrete paracrine factor(s) that inhibit peritubular myoid cell proliferation: identification of heparinoids as likely candidates.
    Tung PS; Fritz IB
    J Cell Physiol; 1991 Jun; 147(3):470-8. PubMed ID: 1712360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell invasion of three-dimensional matrices of defined composition: evidence for a specific role for heparan sulfate in rodent cell lines.
    Robertson NP; Starkey JR; Hamner S; Meadows GG
    Cancer Res; 1989 Apr; 49(7):1816-23. PubMed ID: 2522348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anticoagulant effect of heparan sulfate and dermatan sulfate.
    Teien AN; Abildgaard U; Höök M
    Thromb Res; 1976 Jun; 8(6):859-67. PubMed ID: 134464
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin.
    Hoppensteadt DA; Walenga JM; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 1():60-4. PubMed ID: 2068572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural features and binding properties of chondroitin sulfates, dermatan sulfate, and heparan sulfate.
    Casu B
    Semin Thromb Hemost; 1991; 17 Suppl 1():9-14. PubMed ID: 1906198
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of glycosaminoglycan synthesis during cell growth as observed in an embryonic chick tendon cell culture.
    Ninomiya Y; Nagai Y
    J Biochem; 1979 Jul; 86(1):111-9. PubMed ID: 573261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Density-dependent changes in the amount of sulfated glycosaminoglycans associated with mouse 3T3 cells.
    Underhill CB; Keller JM
    J Cell Physiol; 1976 Sep; 89(1):53-63. PubMed ID: 134041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form.
    Presta M; Maier JA; Rusnati M; Ragnotti G
    J Cell Physiol; 1989 Jul; 140(1):68-74. PubMed ID: 2500452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.